Journal of Inherited Metabolic Disease

, Volume 28, Issue 5, pp 639–649 | Cite as

Living with phenylketonuria: Perspectives of patients and their families

  • C. Bilginsoy
  • N. Waitzman
  • C. O. Leonard
  • S. L. Ernst
Article

Summary

This study surveyed PKU patients and their primary caretakers to assess their current management practices, the barriers to effective management, and the potential utility of a home monitor in managing PKU. A survey instrument was mailed to caretakers of all 50 patients with PKU in Utah between the ages of 2 and 18 years in 1997 (response rate 64%). It included separate components for caretakers and patients aged 10 to 18 years. Although there was uneven compliance with recommended practices, caretakers universally recognized the negative consequences of not adhering to the low-protein diet. There was, however, disagreement regarding such consequences among the older children surveyed. The primary obstacles cited to better adherence were time constraints and stress associated with food preparation and record-keeping, and the restrictions imposed on social life. Phenylalanine test results were regarded as the principal signal for the need for dietary adjustment. Despite the facts that obstacles to dietary adherence are multifaceted and that no single intervention would therefore serve as a panacea, a large majority of respondents believed a home monitor would facilitate better management of PKU through more regular and timely feedback.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Awiszus D, Unger I (1990) Coping with PKU: results of narrative interviews with parents. Eur J Pediatr 149: S45–51.CrossRefPubMedGoogle Scholar
  2. Fisch RO, Matalon R, Weisberg S, Michals K (1997) Phenylketonuria: current dietary treatment practices in the United States and Canada. J Am Coll Nutr 16: 147–151.PubMedGoogle Scholar
  3. Glasgow RE, Anderson RM (1999) In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed [letter; comment]. Diabetes Care 22: 2090–2092.PubMedGoogle Scholar
  4. Koch R, Azen CG, Hurst N, Friedman EG, Fishler K (1987) The effects of diet discontinuation in children with phenylketonuria. Eur J Pediatr 146: A12–16.CrossRefPubMedGoogle Scholar
  5. Koch R, Burton B, Hoganson G, et al (2002) Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis 25: 333–346.CrossRefPubMedGoogle Scholar
  6. Medical Research Council Working Party on Phenylketonuria (1993a) Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. BMJ 306: 115–119.Google Scholar
  7. Medical Research Council Working Party on Phenylketonuria (1993b) Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68: 426–427.Google Scholar
  8. NIH Consensus Development Panel (2001) National Institutes of Health consensus development conference statement. Phenylketonuria: screening and management, October 16–18, 2000. Pediatrics 108: 972–982.Google Scholar
  9. Peterson K, Slover R, Gass S, Seltzer WK, McCabe LL, McCabe ER (1988) Blood phenylalanine estimation for the patient with phenylketonuria using a portable device. Biochem Med Metab Biol 39: 98–104.CrossRefPubMedGoogle Scholar
  10. Pietz J, Benninger C, Schmidt H, Scheffner D, Bickel H (1988) Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early. Eur J Pediatr 147: 361–367.CrossRefPubMedGoogle Scholar
  11. Prince AP, McMurray MP, Buist NR (1997) Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. J Inherit Metab Dis 20: 486–498.CrossRefPubMedGoogle Scholar
  12. Ris MD, Williams SE, Hunt MM, Berry HK, Leslie N (1994) Early-treated phenylketonuria: adult neuropsychologic outcome. J Pediatr 124: 388–392.PubMedGoogle Scholar
  13. Rylance G (1989) Outcome of early detected and early treated phenylketonuria patients. Postgrad Med J 65: S7–9.PubMedGoogle Scholar
  14. Seashore MR, Wappner R, Cho S, de la Cruz F (1999) Development of guidelines for treatment of children with phenylketonuria: report of a meeting at the National Institute of Child Health and Human Development held August 15, 1995, National Institutes of Health, Bethesda, Maryland. Pediatrics 104: e67.CrossRefPubMedGoogle Scholar
  15. Shulman S, Fisch RO, Zempel CE, Gadish O, Chang PN (1991) Children with phenylketonuria: the interface of family and child functioning. J Dev Behav Pediatr 12: 315–321.PubMedGoogle Scholar
  16. Smith I, Beasley MG, Wollf OH, Ades AE (1988) Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J Pediatr 112: 403–408.PubMedGoogle Scholar
  17. Waitzman NJ, Bilginsoy C, Leonard CO, Ernst S, Prince A (2004) The effect of phenylalanine test frequency on management of phenylketonuria (PKU). University of Utah.Google Scholar
  18. Wappner R, Cho S, Kronmal RA, Schuett V, Seashore MR (1999) Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors. Pediatrics 104: e68.CrossRefPubMedGoogle Scholar
  19. Weglage J, Funders B, Wilken B, et al (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr 151: 522–525.CrossRefPubMedGoogle Scholar
  20. Wendel U, Langenbeck (1996) Towards self-monitoring and self-treatment in phenylketonuria—way to better diet compliance. Eur J Pediatr 155: S105–107.PubMedGoogle Scholar

Copyright information

© SSIEM and Springer 2005

Authors and Affiliations

  • C. Bilginsoy
    • 1
    • 3
  • N. Waitzman
    • 1
  • C. O. Leonard
    • 2
  • S. L. Ernst
    • 2
  1. 1.Department of EconomicsUniversity of UtahSalt Lake CityUSA
  2. 2.Department of PediatricsUniversity of UtahSalt Lake CityUSA
  3. 3.Department of EconomicsUniversity of UtahSalt Lake CityUSA

Personalised recommendations